Early this week, the prosecution in the TRU Colors double homicide laid groundwork of where it suspects the defendants were ...

NewLimit, which plans to take its young-again cell reprogramming therapy into the clinic next year, raised a $435 million ...

Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36Single-dose of miv-cel delivered ...

A team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences (IN), a joint center of the Spanish ...

Medical University of South Carolina (MUSC) researchers have developed an engineered stem cell treatment capable of reversing ...

The Transgenerational Cellular Reset: Rather than applying a temporary biochemical block to neural pathways, Dr. Maiarú’s approach attempts a full biological reset. The stem cell particles are ...

In a groundbreaking study, Stevens researchers show how colorectal cancers can evolve from mature intestinal cells that ...

Cancer immunotherapy has entered a transformative era, providing durable benefits to many patients. However, a substantial subset of malignancies remains ...

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

A newly published review article highlights the critical role of fatty acid metabolism in shaping the tumor microenvironment and influencing cancer progression, offering fresh perspectives for the ...

Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...